PRLog - Apr. 26, 2012 - NEEDHAM, Mass. -- NEEDHAM, MASS. – Cambridge Healthtech Institute’s Insight Pharma Affiliated Reports Collection announces the Cross-Border M&A Activity In Pharmaceutical & Healthcare Industry Report, published by Global Business Intelligence.
This report is an essential source of data and trend analysis on cross border mergers and acquisitions (M&As) and asset transactions in the pharmaceuticals industry. The report provides detailed information on cross border and domestic M&As and asset transactions registered in the pharmaceuticals industry in 2011. The report provides detailed comparative data on the number of deals and their value in the last five quarters segregated into domestic and cross border transactions.
Scope of the report:
• Analysis of the cross border M&A trends for the pharmaceutical industry in the global arena.
• Analysis of M&As and asset transactions in the pharmaceutical industry.
• Information on the top deals happened in the pharmaceutical industry.
• Geographies covered include – North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa.
For more information and to purchase this Insight Pharma Report, visit: http://www.InsightPharmaReports.com
About Insight Pharma Reports
Insight Pharma Reports are written by experts in consulting and industry who collaborate with us to provide a series of reports that evaluate the salient issues in pharmaceutical technology, business, and therapy markets. Insight Pharma Reports are used by leading pharmaceutical, biotech, diagnostic, consulting, and financial companies to keep abreast of the latest advances in pharmaceutical R&D, their potential applications and business impacts, and their current and future position in the marketplace. Insight Pharma Reports is a division within Cambridge Healthtech Institute. http://www.InsightPharmaReports.com
Insight Pharma Reports offers our Affiliated Reports Collection which provides a repository of additional scientific and business resources. For more information, visit http://www.insightpharmareports.com/